Skip to main content
. 2015 Apr 27;10(4):e0124839. doi: 10.1371/journal.pone.0124839

Fig 6. Inhibition of CD4 binding to gp120 by HbAHP-25. gp120 coated wells were incubated with HbAHP-25 for 30 min and then with recombinant CD4 for 1 hr.

Fig 6

Following this, wells were incubated with anti-CD4 monoclonal antibody for 1 hr and then HRP-labeled goat-anti human secondary antibody was added. Wells not treated with HbAHP-25 were used as a control (No Peptide), and 0.1μM VRC01 antibody was used as a control to inhibit CD4 binding. Wells not having CD4 show the background absorbance (No CD4) (**p<0.01; ***p<0.001).